Various attempts have been tried to arrest T1D; these include mainly immune depressing therapies like anti-lymphocyte serum (3) and other immune antibodies (4) as well as antigen treatments with beta-cell autoantigens like Glutamic Acid Decarboxylase (GAD) (5) or insulin (6). This evidence concerns the gene INS and type 1 diabetes mellitus.